Correlation Between Boston Scientific and Demant AS

Can any of the company-specific risk be diversified away by investing in both Boston Scientific and Demant AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and Demant AS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Boston Scientific Corp and Demant AS ADR, you can compare the effects of market volatilities on Boston Scientific and Demant AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of Demant AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and Demant AS.

Diversification Opportunities for Boston Scientific and Demant AS

-0.74

Correlation Coefficient

Boston Scientific  Demant AS

Pay attention - limited upside

The 3 months correlation between Boston and Demant is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and Demant AS ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Demant AS ADR and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with Demant AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Demant AS ADR has no effect on the direction of Boston Scientific i.e., Boston Scientific and Demant AS go up and down completely randomly.

Pair Corralation between Boston Scientific and Demant AS

Considering the 90-day investment horizon Boston Scientific Corp is expected to generate 1.35 times more return on investment than Demant AS. However, Boston Scientific is 1.35 times more volatile than Demant AS ADR. It trades about 0.16 of its potential returns per unit of risk. Demant AS ADR is currently generating about -0.18 per unit of risk. If you would invest  8,196  in Boston Scientific Corp on September 4, 2024 and sell it today you would earn a total of  847.00  from holding Boston Scientific Corp or generate 10.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Boston Scientific Corp  vs.  Demant AS ADR

Boston Scientific Corp

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Demant AS ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Demant AS ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Boston Scientific and Demant AS

The main advantage of trading using opposite Boston Scientific and Demant AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, Demant AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Demant AS will offset losses from the drop in Demant AS's long position.

The idea behind Boston Scientific Corp and Demant AS ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.